Acute lymphoblastic leukaemia: open trials in Sweden

14 open trials have a site in Sweden. Registry data; only the trial team decides who can take part.

NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Queen Silvia Childrens Hospital - Sahlgrenska University Hospital - Vastra Gotalandsregionen, Gothenburg
Registry updated 2026-10-30
NCT07570173
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Karolinska University Hospital, Solna
Registry updated 2026-10-30
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Queen Silvia Childrens Hospital - Sahlgrenska University Hospital - Vaestra Goetalandsregionen, Gothenburg · Region Oestergoetland, Linkoping · Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna · Region Vaesterbotten, Umea · Uppsala University Hospital, Uppsala
Registry updated 2026-10-26
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Queen Silvia Childrens Hospital - Sahlgrenska University Hospital - Vastra Gotalandsregionen, Gothenburg · Linkoping University Hospital Region Ostergotland, Linkoping · Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Stockholm · Norrlands University Hospital, Umeå · Uppsala University Hospital, Uppsala
Registry updated 2026-10-19
NCT03934372
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
Trial Treatment · Phase 1/2 · Incyte Biosciences International Sàrl
Karolinska University Hospital, Solna, Stockholm
Registry updated 2026-10-09
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Trial Treatment · Phase 2 · Pfizer
Sahlgrenska Universitetssjukhuset, Östra, Gothenburg · Region Skane Skanes Universitetssjukhus, Lund · Karolinska University Hospital, Solna
Registry updated 2026-09-24
NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung
Queen Silvia Childrens Hospital - Sahlgrenska University Hospital - Vaestra Goetalandsregionen, Gothenburg · Karolinska University Hospital, Huddinge · Region Skane Skanes Universitetssjukhus, Lund · Uppsala University Hospital, Uppsala
Registry updated 2026-09-04
NCT03911128
A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Research · Mats Heyman
Sahlgrenska University Hospital, Section for Haematology and coagulation, Gothenburg · Sahlgrenska University Hospital, Dept of Paediatric Haematology and Oncology, Gothenburg · Linköping University Hospital, Dept of Haematology, Linköping · Linköping University Hospital, Dept of Paediatrics, Linköping · Skåne University Hospital, Dept of Haematology, Lund · Skåne University Hospital, Dept of Paediatrics, Lund · Örebro University Hospital, Section for Haematology, Örebro · Karolinska University Hospital, Patient area Haematology, Stockholm · Karolinska University Hospital, Dept of Paediatric Oncology and Haematology, Stockholm · Norrland University Hospital, Dept of Haematology, Umeå · Norrland University Hospital, Dept of Paediatrics, Umeå · Uppsala University Hospital, Dept of Haematology, Uppsala · Uppsala University Hospital, Dept of Paediatric Haematology and Oncology, Uppsala
Registry updated 2026-08-13
NCT04307576
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 3 · Mats Heyman
Sahlgrenska University Hospital-Vaestra Goetalandsregionen, Goteborg · Queen Silvia Childrens Hospital - Sahlgrenska University Hospital - Vaestra Goetalandsregionen, Gothenburg · Region Oestergoetland, Linkoping · Region Skane Skanes Universitetssjukhus, Lund · Region Oerebro lan, Orebro · Region Stockholm – SLSO, Stockholm · Region Vasterbotten, Umea · Region Uppsala, Uppsala
Registry updated 2026-08-12
2023-504694-20-00
Inotuzumab ozogamicin for Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1/2 · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Karolinska University Hospital, Solna
Registry updated 2026-06-04
NCT03590171
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Trial Treatment · Phase 2 · Charite University, Berlin, Germany
University Hospital Stockholm, Stockholm
Registry updated 2026-03-17
NCT05658640
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Karolinska University Hospital, Stockholm
Registry updated 2025-09-16
NCT05745714
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Karolinska University Hospital, Stockholm
Registry updated 2025-09-16
NCT05751044
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Karolinska University Hospital, Stockholm
Registry updated 2025-09-16

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error